DURYSTA 10 ug/1

DURYSTA 10 ug/1 is an intracameral implant containing bimatoprost, designed for ophthalmic use. It is commonly used to reduce intraocular pressure in certain eye conditions. This implant is manufactured by Allergan, Inc. in the USA.

DURYSTA 10 ug/1 is primarily used to lower intraocular pressure in the eye. It is often prescribed for conditions that require long-term management of elevated eye pressure. The implant is inserted into the eye to provide sustained release of bimatoprost, aiding in the reduction of intraocular pressure over time.

Common effects of DURYSTA 10 ug/1 may include temporary redness or irritation at the site of implantation. Some users may experience changes in eye color or eyelash growth. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

DURYSTA 10 ug/1 should be handled with care to avoid contamination. It is important to follow proper sterile techniques during administration. The implant should be stored as directed to maintain its efficacy. Always consult a healthcare provider before use to ensure it is suitable for your specific condition.

DURYSTA 10 ug/1 may interact with other medications, particularly those used to treat eye conditions. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the implant's efficacy.